ES2115733T3 - Composicion antialergica para uso oftalmico o nasal. - Google Patents

Composicion antialergica para uso oftalmico o nasal.

Info

Publication number
ES2115733T3
ES2115733T3 ES93310464T ES93310464T ES2115733T3 ES 2115733 T3 ES2115733 T3 ES 2115733T3 ES 93310464 T ES93310464 T ES 93310464T ES 93310464 T ES93310464 T ES 93310464T ES 2115733 T3 ES2115733 T3 ES 2115733T3
Authority
ES
Spain
Prior art keywords
ophthalmic
composition
antialergic
nasal use
antiallergic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93310464T
Other languages
English (en)
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farchim S A
Original Assignee
Farchim S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farchim S A filed Critical Farchim S A
Application granted granted Critical
Publication of ES2115733T3 publication Critical patent/ES2115733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE AQUI UNA COMPOSICION ANTIALERGICA PARA USO NASAL U OFTALMICO, QUE COMPRENDE CETERICINA O UNA SAL DE LA MISMA COMO INGREDIENTE ACTIVO. LA COMPOSICION ANTIALERGICA PUEDE CONTENER ADEMAS UN COMPUESTO DE CICLODEXTRINA, ASI COMO UN AGENTE TENSOACTIVO Y/O UN POLIMERO SOLUBLE EN AGUA.
ES93310464T 1992-12-25 1993-12-23 Composicion antialergica para uso oftalmico o nasal. Expired - Lifetime ES2115733T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (1)

Publication Number Publication Date
ES2115733T3 true ES2115733T3 (es) 1998-07-01

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93310464T Expired - Lifetime ES2115733T3 (es) 1992-12-25 1993-12-23 Composicion antialergica para uso oftalmico o nasal.

Country Status (23)

Country Link
US (1) US5419898A (es)
EP (1) EP0605203B1 (es)
JP (1) JP3683595B2 (es)
KR (1) KR100276743B1 (es)
CN (1) CN1050514C (es)
AT (1) ATE164068T1 (es)
AU (1) AU666413B2 (es)
BG (1) BG61101B1 (es)
CA (1) CA2112014C (es)
CZ (1) CZ283029B6 (es)
DE (1) DE69317537T2 (es)
DK (1) DK0605203T3 (es)
ES (1) ES2115733T3 (es)
FI (1) FI111805B (es)
HU (2) HU218672B (es)
LT (1) LT3344B (es)
LV (1) LV10688B (es)
NO (2) NO304176B1 (es)
NZ (1) NZ250519A (es)
PL (1) PL173347B1 (es)
RU (1) RU2130774C1 (es)
SK (1) SK279503B6 (es)
TW (1) TW401300B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
WO1998013001A1 (en) * 1996-09-27 1998-04-02 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
WO2000012137A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
CN101632642B (zh) * 2002-01-15 2011-06-08 Ucb法奇姆股份有限公司 口感和稳定性改善的配方
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
BRPI0513455A (pt) * 2004-07-22 2008-05-06 Pfizer Prod Inc formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
CA2609659C (en) 2005-05-26 2014-01-28 Neuron Systems, Inc. Azanaphthalenes, compositions and methods for treating retinal disease
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
JP2009517346A (ja) * 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
EP1994933B1 (en) * 2006-03-13 2017-04-26 R-Tech Ueno, Ltd. Aqueous composition
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
WO2010107689A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
BR112012002067A2 (pt) * 2009-08-12 2017-08-08 Lunan Better Pharmaceutical Co Ltd solução farmacêutica de hidrocloreto de cetirizina
US9096630B2 (en) 2009-11-06 2015-08-04 Yale University Amphiphilic compositions and methods for preparing and using same
BR112014012985B1 (pt) 2011-11-29 2020-05-12 Jurox Pty Ltd Composição farmacêutica injetável, seu método de produção e uso, bem como método de conservação de uma composição farmacêutica injetável e uso de pelo menos um co-solvente e pelo menos um conservante
AU2014209387B2 (en) 2013-01-23 2018-11-01 Aldeyra Therapeutics, Inc. Toxic aldehyde related diseases and treatment
CA2996183A1 (en) 2015-08-21 2017-03-02 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
CA3016759A1 (en) * 2016-02-28 2017-08-31 Aldeyra Therapeutics, Inc. Treatment of allergic eye conditions with cyclodextrins
JP7116490B2 (ja) 2016-05-09 2022-08-10 アルデイラ セラピューティクス， インコーポレイテッド 眼の炎症性障害および疾患の組合せ処置
US11241426B2 (en) 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
US10414732B2 (en) 2017-03-16 2019-09-17 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
WO2019075136A1 (en) 2017-10-10 2019-04-18 Aldeyra Therapeutics, Inc. TREATMENT OF INFLAMMATORY DISORDERS
ES2878107T3 (es) 2018-01-18 2021-11-18 Faes Farma Sa Composiciones oftálmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificación
WO2020033344A1 (en) 2018-08-06 2020-02-13 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CN113056353B (zh) 2018-09-25 2022-11-01 奥尔德拉医疗公司 用于治疗干眼病的调配物
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
HUT69385A (en) 1995-09-28
EP0605203A3 (en) 1994-11-02
KR100276743B1 (ko) 2001-01-15
LV10688A (lv) 1995-06-20
ATE164068T1 (de) 1998-04-15
EP0605203A2 (en) 1994-07-06
DE69317537D1 (de) 1998-04-23
FI935851A (fi) 1994-06-26
JP3683595B2 (ja) 2005-08-17
NO304176B1 (no) 1998-11-09
AU666413B2 (en) 1996-02-08
DE69317537T2 (de) 1998-07-09
NO934630D0 (no) 1993-12-15
JPH06239748A (ja) 1994-08-30
TW401300B (en) 2000-08-11
NZ250519A (en) 1995-03-28
CN1050514C (zh) 2000-03-22
CZ283029B6 (cs) 1997-12-17
PL173347B1 (pl) 1998-02-27
BG61101B1 (bg) 1996-11-29
AU5259793A (en) 1994-07-07
CA2112014C (en) 2004-11-02
SK279503B6 (sk) 1998-12-02
RU2130774C1 (ru) 1999-05-27
CZ283693A3 (en) 1994-07-13
CN1094614A (zh) 1994-11-09
SK147493A3 (en) 1994-07-06
LV10688B (en) 1995-10-20
NO934630L (no) 1994-06-27
FI935851A0 (fi) 1993-12-23
LTIP1669A (en) 1994-10-25
PL301588A1 (en) 1994-06-27
EP0605203B1 (en) 1998-03-18
KR940013511A (ko) 1994-07-15
LT3344B (en) 1995-07-25
HU218672B (hu) 2000-10-28
BG98327A (bg) 1994-08-30
HU9303746D0 (en) 1994-04-28
FI111805B (fi) 2003-09-30
HU211972A9 (en) 1996-01-29
DK0605203T3 (da) 1998-12-07
US5419898A (en) 1995-05-30
CA2112014A1 (en) 1994-06-26

Similar Documents

Publication Publication Date Title
ES2115733T3 (es) Composicion antialergica para uso oftalmico o nasal.
RU93056633A (ru) Антиаллергическая композиция для лечения глаз или носа
DK0694529T3 (da) Alklthio-oximetherderivater samt deres anvendelse som fungicider
ES2110375T3 (es) Nimesulida para uso externo.
ES2071227T3 (es) Composicion para gotas para los ojos.
EP0990648A4 (en) DERIVATIVES OF 4-CHINOLOL AND AGRICULTURAL AND GARDENING BACTERICIDES THAT CONTAIN THEM AS AN ACTIVE COMPONENT
ES2167457T3 (es) Nuevo uso medicinal de un antagonista de 5ht3.
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
MX9203528A (es) Metodos para preparar y utilizar emulsiones estables, oleosas externas-acuosas internas.
NO900612L (no) Preservativ for vandige sammensetninger.
ATE179073T1 (de) Asthma heilmittel
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
IT1197081B (it) Composizione sterilizzante ad attivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
EP1130018A4 (en) DRUGS FOR DRUG ADDICTION
NO163813C (no) Forbindelser inneholdende perfluoralkylgrupper og anvendelse derav som avskummingsmiddel for vandige polymerdispersjoner.
IT8822558A0 (it) Soluzione farmaceutica acquosa per uso oftalmico.
EP0509098A4 (en) Ataractic
FI921475A0 (fi) 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.
DE59301126D1 (de) Wässrige Polymerisatzubereitungen
ES1018918Y (es) Calzado para uso interno.
TH14981EX (th) สารผสมสำหรับต่อต้านภูมิแพ้สำหรับการใช้เกี่ยวกับตาหรือจมูก
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
ES2083319B1 (es) Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.
ES1015180Y (es) Estuche-agenda para uso infantil.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 605203

Country of ref document: ES